Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4

Journal of Lipid Research

Volumn 52, Issue 11, 2011, Pages 1936-1948

  Cooke, Mariana ^a   Orlando, Ulises ^a   Maloberti, Paula ^a   Podestá, Ernesto J ^a   Maciel, Fabiana Cornejo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Arachidonic acid; Breast cancer cells; Leydig cells; Long chain acyl CoA synthetases; Proliferation; Protein tyrosine phosphatases; Steroidogenesis

Indexed keywords

ACSL4 PROTEIN; ARACHIDONIC ACID; CYCLIC AMP; LONG CHAIN FATTY ACID COENZYME A LIGASE; MESSENGER RNA; NSC 87877; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; GENE SILENCING; HUMAN; HUMAN CELL; LEYDIG CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEROIDOGENESIS; STEROIDOGENIC CELL;

ANIMALS; ARACHIDONIC ACID; CELL LINE, TUMOR; CELL PROLIFERATION; COENZYME A LIGASES; CYCLIC AMP; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LEYDIG CELLS; MALE; MICE; PHOSPHOPROTEINS; PLASMIDS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; QUINOLINES; RATS; RNA INTERFERENCE; STEROIDS;

EID: 80054117545     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M015552     Document Type: Article

References (60)

1. Lewin, T. M., J. H. Kim, D. A. Granger, J. E. Vance, and R. A. Coleman. 2001. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J. Biol. Chem. 276: 24674-24679.
2. Van Horn, C. G., J. M. Caviglia, L. O. Li, S. Wang, D. A. Granger, and R. A. Coleman. 2005. Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6. Biochemistry. 44: 1635-1642. (Pubitemid 40204404)
3. Kim, J. H., T. M. Lewin, and R. A. Coleman. 2001. Expression and characterization of recombinant rat acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. J. Biol. Chem. 276: 24667-24673.
4. Mashek, D. G., K. E. Bornfeldt, R. A. Coleman, J. Berger, D. A. Bernlohr, P. Black, C. C. DiRusso, S. A. Farber, W. Guo, N. Hashimoto, et al. 2004. Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J. Lipid Res. 45: 1958-1961. (Pubitemid 40990889)
5. Soupene, E., and F. A. Kuypers. 2008. Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood). 233: 507-521. (Pubitemid 351657352)
6. Mashek, D. G., L. O. Li, and R. A. Coleman. 2006. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J. Lipid Res. 47: 2004-2010. (Pubitemid 44401988)
7. Kang, M. J., T. Fujino, H. Sasano, H. Minekura, N. Yabuki, H. Nagura, H. Iijima, and T. T. Yamamoto. 1997. A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis. Proc. Natl. Acad. Sci. USA. 94: 2880-2884. (Pubitemid 27157233)
8. Sung, Y. K., M. K. Park, S. H. Hong, S. Y. Hwang, M. H. Kwack, J. C. Kim, and M. K. Kim. 2007. Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. 39: 477-482.
9. Cao, Y., K. B. Dave, T. P. Doan, and S. M. Prescott. 2001. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res. 61: 8429-8434. (Pubitemid 33131120)
10. Monaco, M. E., C. J. Creighton, P. Lee, X. Zou, M. K. Topham, and D. M. Stafforini. 2010. Expression of long-chain fatty acyl-CoA synthetase 4 in breast and prostate cancers is associated with sex steroid hormone receptor negativity. Transl. Oncol. 3: 91-98.
11. Cornejo Maciel, F., P. Maloberti, I. Neuman, F. Cano, R. Castilla, F. Castillo, C. Paz, and E. J. Podesta. 2005. An arachidonic acid-preferring acyl-CoA synthetase is a hormone-dependent and obligatory protein in the signal transduction pathway of steroidogenic hormones. J. Mol. Endocrinol. 34: 655-666. (Pubitemid 40903591)
12. Maloberti, P., R. Castilla, F. Castillo, F. C. Maciel, C. F. Mendez, C. Paz, and E. J. Podesta. 2005. Silencing the expression of mitochondrial acyl-CoA thioesterase I and acyl-CoA synthetase 4 inhibits hormone-induced steroidogenesis. FEBS J. 272: 1804-1814. (Pubitemid 40516229)
13. Maloberti, P., R. C. Lozano, P. G. Mele, F. Cano, C. Colonna, C. F. Mendez, C. Paz, and E. J. Podesta. 2002. Concerted regulation of free arachidonic acid and hormone-induced steroid synthesis by acyl-CoA thioesterases and acyl-CoA synthetases in adrenal cells. Eur. J. Biochem. 269: 5599-5607. (Pubitemid 35365548)
14. Duarte, A., A. F. Castillo, R. Castilla, P. Maloberti, C. Paz, E. J. Podesta, and F. Cornejo Maciel. 2007. An arachidonic acid generation/export system involved in the regulation of cholesterol transport in mitochondria of steroidogenic cells. FEBS Lett. 581: 4023-4028. (Pubitemid 47212113)
15. Golej, D. L., B. Askari, F. Kramer, S. Barnhart, A. Vivekanandan-Giri, S. Pennathur, and K. E. Bornfeldt. 2011. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells. J. Lipid Res. 52: 782-793.
16. Sung, Y. K., S. Y. Hwang, M. K. Park, H. I. Bae, W. H. Kim, J. C. Kim, and M. Kim. 2003. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma. Cancer Sci. 94: 421-424. (Pubitemid 36790473)
17. Maloberti, P. M., A. B. Duarte, U. D. Orlando, M. E. Pasqualini, A. R. Solano, C. Lopez-Otin, and E. J. Podesta. 2010. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. PLoS ONE. 5: e15540.
18. Cano, F., C. Poderoso, F. Cornejo Maciel, R. Castilla, P. Maloberti, F. Castillo, I. Neuman, C. Paz, and E. J. Podesta. 2006. Protein tyrosine phosphatases regulate arachidonic acid release, StAR induction and steroidogenesis acting on a hormone-dependent arachidonic acid-preferring acyl-CoA synthetase. J. Steroid Biochem. Mol. Biol. 99: 197-202. (Pubitemid 43786266)
19. Paz, C., F. Cornejo Maciel, C. Mendez, and E. J. Podesta. 1999. Corticotropin increases protein tyrosine phosphatase activity by a cAMP-dependent mechanism in rat adrenal gland. Eur. J. Biochem. 265: 911-918. (Pubitemid 29507802)
20. Poderoso, C., F. C. Maciel, A. Gorostizaga, P. Bey, C. Paz, and E. J. Podesta. 2002. The obligatory action of protein tyrosine phosphatases in ACTH-stimulated steroidogenesis is exerted at the level of StAR protein. Endocr. Res. 28: 413-417. (Pubitemid 36042494)
21. Maciel, F. C., C. Poderoso, A. Gorostizaga, C. Paz, and E. J. Podesta. 2001. LH/chorionic gonadotropin signaling pathway involves protein tyrosine phosphatase activity downstream of protein kinase A activation: evidence of an obligatory step in steroid production by Leydig cells. J. Endocrinol. 170: 403-411. (Pubitemid 32771441)
22. Paz, C., F. Cornejo Maciel, P. Maloberti, L. P. Walsh, D. M. Stocco, and E. J. Podesta. 2002. Protein tyrosine phosphatases are involved in LH/chorionic gonadotropin and 8Br-cAMP regulation of steroidogenesis and StAR protein levels in MA-10 Leydig cells. J. Endocrinol. 175: 793-801. (Pubitemid 36054248)
23. Vilgrain, I., A. Chinn, I. Gaillard, E. M. Chambaz, and J. J. Feige. 1998. Hormonal regulation of focal adhesions in bovine adrenocortical cells: induction of paxillin dephosphorylation by adrenocorticotropic hormone. Biochem. J. 332: 533-540. (Pubitemid 28271887)
24. Rocchi, S., I. Gaillard, E. van Obberghen, E. M. Chambaz, and I. Vilgrain. 2000. Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase. Biochem. J. 352: 483-490. (Pubitemid 32011442)
25. Feng, G. S., C. C. Hui, and T. Pawson. 1993. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science. 259: 1607-1611. (Pubitemid 23114639)
26. Vogel, W., R. Lammers, J. Huang, and A. Ullrich. 1993. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science. 259: 1611-1614. (Pubitemid 23114640)
27. Dance, M., A. Montagner, J-P. Salles, A. Yart, and P. Raynal. 2008. The molecular functions of Shp2 in the Ras/mitogen-activated protein kinase (ERK1/2) pathway. Cell. Signal. 20: 453-459.
28. Matozaki, T., Y. Murata, Y. Saito, H. Okazawa, and H. Ohnishi. 2009. Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation. Cancer Sci. 100: 1786-1793.
29. Zhou, X., J. Coad, B. Ducatman, and Y. M. Agazie. 2008. SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis. Histopathology. 53: 389-402.
30. Zhou, X. D., and Y. M. Agazie. 2008. Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells. Cell Death Differ. 15: 988-996.
31. Ascoli, M. 1981. Characterization of several clonal lines of cultured ley dig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology. 108: 88-95. (Pubitemid 11212802)
32. Catt, K. J., T. Tsuruhara, C. Mendelson, J. M. Ketelslegers, and M. L. Dufau. 1974. Gonadotroping binding and activation of the interstitial cells of the testis. Curr. Top. Mol. Endocrinol. 1: 1-30.
33. Gauthier, A. S., O. Furstoss, T. Araki, R. Chan, B. G. Neel, D. R. Kaplan, and F. D. Miller. 2007. Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome. Neuron. 54: 245-262. (Pubitemid 46562561)
34. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
35. Burridge, K., and A. Nelson. 1995. An in-gel assay for protein tyrosine phosphatase activity: detection of widespread distribution in cells and tissues. Anal. Biochem. 232: 56-64.
36. Markova, B., P. Gulati, P. A. Herrlich, and F. D. Bohmer. 2005. Investigation of protein-tyrosine phosphatases by in-gel assays. Methods. 35: 22-27. (Pubitemid 39647575)
37. Castillo, F., F. Cano, P. Maloberti, R. Castilla, I. Neuman, C. Poderoso, C. Paz, E. J. Podesta, and F. Cornejo Maciel. 2004. Tyrosine phosphates act on steroidogenesis through the activation of arachidonic acid release. Endocr. Res. 30: 623-627. (Pubitemid 40070142)
38. Chan, Y. L., A. Lin, J. McNally, D. Peleg, O. Meyuhas, and I. G. Wool. 1987. The primary structure of rat ribosomal protein L19. A determination from the sequence of nucleotides in a cDNA and from the sequence of amino acids in the protein. J. Biol. Chem. 262: 1111-1115. (Pubitemid 17028421)
39. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65: 55-63. (Pubitemid 14203433)
40. Alvarez-Díaz, S., N. Valle, J. M. García, C. Peña, J. M. P. Freije, V. Quesada, A. Astudillo, F. Bonilla, C. López- Otín, and A. Muñoz. 2009. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J. Clin. Invest. 119: 2343-2358.
41. Solano, A. R., L. Dada, and E. J. Podesta. 1988. Lipoxygenase products as common intermediates in cyclic AMP-dependent and -independent adrenal steroidogenesis in rats. J. Mol. Endocrinol. 1: 147-154. (Pubitemid 19046706)
42. Castillo, A. F., F. C. Maciel, R. Castilla, A. Duarte, P. Maloberti, C. Paz, and E. J. Podesta. 2006. cAMP increases mitochondrial cholesterol transport through the induction of arachidonic acid release inside this organelle in Leydig cells. FEBS J. 273: 5011-5021. (Pubitemid 44673292)
43. Sakuma, S., Y. Fujimoto, A. Kitao, H. Sakamoto, H. Nishida, and T. Fujita. 1999. Simultaneous measurement of prostaglandin and arachidonoyl CoA formed from arachidonic acid in rabbit kidney medulla microsomes: the roles of Zn2+ and Cu2+ as modulators of formation of the two products. Prostaglandins Leukot. Essent. Fatty Acids. 61: 105-112. (Pubitemid 29454331)
44. Chen, L., S-S. Sung, M. L. R. Yip, H. R. Lawrence, Y. Ren, W. C. Guida, S. M. Sebti, N. J. Lawrence, and J. Wu. 2006. Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor. Mol. Pharmacol. 70: 562-570. (Pubitemid 44092317)
45. Lewin, T. M., C. G. Van Horn, S. K. Krisans, and R. A. Coleman. 2002. Rat liver acyl-CoA synthetase 4 is a peripheral-membrane protein located in two distinct subcellular organelles, peroxisomes, and mitochondrial-associated membrane. Arch. Biochem. Biophys. 404: 263-270. (Pubitemid 34913557)
46. Cao, Y., K. J. Murphy, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 2000. Expression of fatty acid-CoA ligase 4 during development and in brain. FEBS Lett. 467: 263-267. (Pubitemid 30081747)
47. Cho, Y-Y., M-J. Kang, S. Ogawa, Y. Yamashita, T. Fujino, and T. T. Yamamoto. 2000. Regulation by adrenocorticotropic hormone and arachidonate of the expression of acyl-CoA synthetase 4, an arachidonate-preferring enzyme expressed in steroidogenic tissues. Biochem. Biophys. Res. Commun. 274: 741-745. (Pubitemid 30663690)
48. Flint, A. J., T. Tiganis, D. Barford, and N. K. Tonks. 1997. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA. 94: 1680-1685.
49. Podesta, E. J., M. L. Dufau, and K. J. Catt. 1976. Adenosine 3′,5′-monophosphate-dependent protein kinase of Leydig cells: in vitro activation and relationship to gonadotropin action upon cyclic AMP and steroidogenesis. FEBS Lett. 70: 212-216.
50. Rae, P. A., N. S. Gutmann, J. Tsao, and B. P. Schimmer. 1979. Mutations in cyclic AMP-dependent protein kinase and corticotropin (ACTH)-sensitive adenylate cyclase affect adrenal steroidogenesis. Proc. Natl. Acad. Sci. USA. 76: 1896-1900. (Pubitemid 9207022)
51. Arakane, F., S. R. King, Y. Du, C. B. Kallen, L. P. Walsh, H. Watari, D. M. Stocco, and J. F. Strauss 3rd. 1997. Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J. Biol. Chem. 272: 32656-32662. (Pubitemid 28011957)
52. Mañes, S., E. Mira, C. Gomez-Mouton, Z. J. Zhao, R. A. Lacalle, and C. Martinez-A. 1999. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol. Cell. Biol. 19: 3125-3135. (Pubitemid 29144557)
53. Rivard, N., F. R. McKenzie, J. M. Brondello, and J. Pouyssegur. 1995. The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors. J. Biol. Chem. 270: 11017-11024.
54. Higashi, H., A. Nakaya, R. Tsutsumi, K. Yokoyama, Y. Fujii, S. Ishikawa, M. Higuchi, A. Takahashi, Y. Kurashima, Y. Teishikata, et al. 2004. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279: 17205-17216. (Pubitemid 38560478)
55. Xu, R., Y. Yu, S. Zheng, X. Zhao, Q. Dong, Z. He, Y. Liang, Q. Lu, Y. Fang, X. Gan, X. Xu, S. Zhang, Q. Dong, X. Zhang, and G.-S. Feng. 2005. Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia. Blood. 106: 3142-3149. (Pubitemid 41565912)
56. Daly, R. J., H. Gu, J. Parmar, S. Malaney, R. J. Lyons, R. Kairouz, D. R. Head, S. M. Henshall, B. G. Neel, and R. L. Sutherland. 2002. OThe docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene. 21: 5175-5181.
57. Martinelli, S., C. Carta, E. Flex, F. Binni, E. L. Cordisco, S. Moretti, E. Puxeddu, M. Tonacchera, A. Pinchera, H. P. McDowell, C. Dominici, A. Rosolen, C. Di Rocco, R. Riccardi, P. Celli, M. Picardo, M. Genuardi, P. Grammatico, M. Sorcini, and M. Tartaglia. 2006. Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors. Cancer Genet. Cytogenet. 166: 124-129.
58. Arrandale, J. M., A. Gore-Willse, S. Rocks, J.-M. Ren, J. Zhu, A. Davis, J. N. Livingston, and D. U. Rabin. 1996. Insulin signaling in mice expressing reduced levels of Syp. J. Biol. Chem. 271: 21353-21358. (Pubitemid 26292997)
59. Krajewska, M., S. Banares, E. E. Zhang, X. Huang, M. Scadeng, U. S. Jhala, G.-S. Feng, and S. Krajewski. 2008. Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase. Am. J. Pathol. 172: 1312-1324. (Pubitemid 351671544)
60. Asante-Appiah, E., and B. P. Kennedy. 2003. Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am. J. Physiol. Endocrinol. Metab. 284: E663-670. (Pubitemid 36323858)